BofA Securities Downgrades Core Laboratories (CLB) to Underperform
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $13.36 -1.76%
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
BofA Securities analyst Chase Mulvehill downgraded Core Laboratories (NYSE: CLB) from Neutral to Underperform with a price target of $21.50 (from $26.50).
For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on Core Laboratories click here.
Shares of Core Laboratories closed at $22.31 yesterday.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Old Dominion Freight Line (ODFL) PT Raised to $233 at TD Cowen
- Nomura/Instinet Downgrades T&D Holdings Inc (8795:JP) (TDHOY) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
